In doing so, we advocate for a paradigm that moves beyond traditional indications, embracing the full spectrum of GLP-1R agonists in areas such as primary prevention, microvascular protection, and metabolic liver disease, and metabolic disorders that include cardio-kidney-metabolic (CKM) syndromea systemic disorder characterized by interrelated metabolic, renal, and cardiovascular dysfunction and a broader cardio-renal-metabolic axis that includes central obesity, insulin resistance, dyslipidemia, hypertension, and pre-diabetic states
First: the legal entity name of the clinical group making prescribing decisions
If you have a family history of prostate cancer, you should also consider screenings at a younger age, and your healthcare professional will discuss options with you
It works by signaling your pancreas to release insulin after meals, slowing digestion, and helping you feel fuller longerultimately controlling appetite and blood sugar more effectively
doi: 10.1186/s13052-022-01319-1 73 CrinASchiaffiniRCiampaliniPSperaSBeccariaLBenziFet al